Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Theophylline for COVID-19 Related Smell Dysfunction
NCT05947643Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of theophylline in Olfactory dysfunction, sponsored by Washington University School of Medicine. Started Nov 2022; status: completed.
02
Drugs
theophylline
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT05947643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947643.